Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Howes

Showing results (231-240 of 443) with videos related to

Pageof 45
Sort By:
Schizophrenia Bulletin|February 1, 2012
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individualsPaul Allen, Judy Luigjes, Oliver D Howes, et al.
The Journal of Antibiotics|January 1, 1995
Synthesis and biological activity of novel cephalosporins containing a (Z)-vinyl dimethylphosphonate groupP W Smith, A J Chamiec, G Chung, et al.
Biophysical Journal|July 2, 1999
The quantum mixed-spin heme state of barley peroxidase: A paradigm for class III peroxidasesB D Howes, C B Schiodt, K G Welinder, et al.
NPJ Schizophrenia|January 9, 2020
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future researchSteven G Potkin, John M Kane, Christoph U Correll, et al.
Behavioural Brain Research|February 26, 2021
Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortexEls F Halff, Marie-Caroline Cotel, Sridhar Natesan, et al.
Acta Psychiatrica Scandinavica|September 10, 2014
The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approachK Beck, R McCutcheon, M A P Bloomfield, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2011
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availabilityPaul R A Stokes, Alice Egerton, Ben Watson, et al.
Genes, Brain, and Behavior|July 3, 2019
Disrupted-in-schizophrenia 1 functional polymorphisms and D<sub>2</sub> /D<sub>3</sub> receptor availability: A [<sup>11</sup> C]-(+)-PHNO imaging studyTarik Dahoun, Matthew M Nour, Rick A Adams, et al.
Schizophrenia Research. Cognition|March 29, 2022
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the artPhilip D Harvey, Marta Bosia, Roberto Cavallaro, et al.
Schizophrenia Research|May 20, 2009
The effect of ageing on grey and white matter reductions in schizophreniaSubrata K Bose, Toby Mackinnon, Mitul A Mehta, et al.
Pageof 45

Showing results (231-240 of 443) with videos related to

Sort By:
Pageof 45
Schizophrenia Bulletin|February 1, 2012
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individualsPaul Allen, Judy Luigjes, Oliver D Howes, et al.
The Journal of Antibiotics|January 1, 1995
Synthesis and biological activity of novel cephalosporins containing a (Z)-vinyl dimethylphosphonate groupP W Smith, A J Chamiec, G Chung, et al.
Biophysical Journal|July 2, 1999
The quantum mixed-spin heme state of barley peroxidase: A paradigm for class III peroxidasesB D Howes, C B Schiodt, K G Welinder, et al.
NPJ Schizophrenia|January 9, 2020
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future researchSteven G Potkin, John M Kane, Christoph U Correll, et al.
Behavioural Brain Research|February 26, 2021
Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortexEls F Halff, Marie-Caroline Cotel, Sridhar Natesan, et al.
Acta Psychiatrica Scandinavica|September 10, 2014
The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approachK Beck, R McCutcheon, M A P Bloomfield, et al.
Journal of Psychopharmacology (Oxford, England)|September 6, 2011
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availabilityPaul R A Stokes, Alice Egerton, Ben Watson, et al.
Genes, Brain, and Behavior|July 3, 2019
Disrupted-in-schizophrenia 1 functional polymorphisms and D<sub>2</sub> /D<sub>3</sub> receptor availability: A [<sup>11</sup> C]-(+)-PHNO imaging studyTarik Dahoun, Matthew M Nour, Rick A Adams, et al.
Schizophrenia Research. Cognition|March 29, 2022
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the artPhilip D Harvey, Marta Bosia, Roberto Cavallaro, et al.
Schizophrenia Research|May 20, 2009
The effect of ageing on grey and white matter reductions in schizophreniaSubrata K Bose, Toby Mackinnon, Mitul A Mehta, et al.
Pageof 45